clinical trial

QUINCY — The Blessing Cancer Center has been selected as one of 51 study locations worldwide participating in a new metastatic breast cancer clinical trial. Metastatic cancer has traveled to other parts of the body from its site of origination. It is estimated that 20 to 30 percent of all breast cancer cases will become…